ConductScience.org, home

Paper35342000

Drug resistant TB - latest developments in epidemiology, diagnostics and management.

Tiberi S and 7 others. Int J Infect Dis, 2022. Cited by 122 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Drug resistant TB - latest developments in epidemiology, diagnostics and management. Papers, record 35342000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35342000

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
PubMed
Journal
Int J Infect Dis
PubMed
Year
2022
PubMed
Publication types
Review, Journal Article
PubMed
Citations, by iCite
122
iCite
Relative citation ratio, by iCite
12.8
iCite
Revised in PubMed
2025-05-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tiberi SSimon
2Utjesanovic NNatasa
3Galvin JJessica
4Centis RRosella
5D'Ambrosio LLia
6van den Boom MMartin
7Zumla AAlimuddin
8Migliori GBGiovanni Battista

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Extensively Drug-Resistant TuberculosisMajor topic
Tuberculosis, Multidrug-ResistantMajor topic
Mycobacterium tuberculosisMajor topic
Humans
Antitubercular Agents
Isoniazid
Rifampin

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed

Source PubMed

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.

PMIDTitleJournalYearIn PapersSource
42,971,965Risk stratification for MDR/RR-TB: a comprehensive integrated patient-level analysis from TB programs and contemporary clinical trials.Nat Commun2026https://conductscience.org/library/papers/42971965PubMed
42,583,028Direct medical costs for drug-resistant tuberculosis inpatients at the national lung hospital, Vietnam: A one-year study.J Public Health Res2026https://conductscience.org/library/papers/42583028PubMed
42,565,573[Drug resistance characteristics of pulmonary tuberculosis and factors associated with rifampicin resistance in Changsha from 2018 to 2025].Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42565573PubMed
42,430,436Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis.PLoS One2026https://conductscience.org/library/papers/42430436PubMed
42,391,193A high centrifugal force-enhanced Ziehl-Neelsen method for improved detection of Mycobacterium tuberculosis.PLoS One2026https://conductscience.org/library/papers/42391193PubMed
42,224,160Experiences and understanding of diagnosis and treatment among drug-resistant extrapulmonary tuberculosis patients: A qualitative study from Central India.PLOS Glob Public Health2026https://conductscience.org/library/papers/42224160PubMed
42,221,368Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018-2024).Open Forum Infect Dis2026https://conductscience.org/library/papers/42221368PubMed
42,197,518Investigating the Antimycobacterial, Antibiofilm, and Antioxidant Activities of Plant Extracts Against Mycobacterium smegmatis.Microorganisms2026https://conductscience.org/library/papers/42197518PubMed
42,197,401Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations.Microorganisms2026https://conductscience.org/library/papers/42197401PubMed
42,115,223Prevalence and associated factors of rifampicin resistance pulmonary tuberculosis among HIV-positive patients in Bahir Dar, Northwest, Ethiopia.Sci Rep2026https://conductscience.org/library/papers/42115223PubMed
42,074,413Predictors of Treatment Outcomes Among HIV-Positive Patients with Drug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: A Retrospective Cohort Study.Int J Environ Res Public Health2026https://conductscience.org/library/papers/42074413PubMed
42,046,646Current and emerging therapies for pulmonary tuberculosis in adults.BMJ Med2026https://conductscience.org/library/papers/42046646PubMed
42,012,189The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F420-Dependent Glucose Dehydrogenase.Proteins2026https://conductscience.org/library/papers/42012189PubMed
41,893,419Evaluating Treatment and Safety Outcomes of a Shorter Regimen for Drug-Resistant TB in Nigeria: An Implementation Research Study.Trop Med Infect Dis2026https://conductscience.org/library/papers/41893419PubMed
41,887,661Armed conflict intensity and inequalities in tuberculosis outcomes in Colombia municipalities, 2008-2019.BMJ Glob Health2026https://conductscience.org/library/papers/41887661PubMed
41,859,056Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection.Infect Drug Resist2026https://conductscience.org/library/papers/41859056PubMed
41,810,308Epidemiology of drug-resistant tuberculosis in Hunan China over a 10-year period.Front Public Health2026https://conductscience.org/library/papers/41810308PubMed
41,742,015Assessing the efficacy of combined treatment using bedaquiline against clinical isolates of multidrug-resistant Mycobacterium tuberculosis in vitro and the macrophage model.BMC Microbiol2026https://conductscience.org/library/papers/41742015PubMed
41,710,375Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report.Infect Drug Resist2026https://conductscience.org/library/papers/41710375PubMed
41,680,935Spatiotemporal epidemiology, geographic hotspots, and risk factor associations of drug-resistant tuberculosis incidence in Indonesia: a Bayesian hierarchical modelling approach.Infect Dis Poverty2026https://conductscience.org/library/papers/41680935PubMed

See all 92 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35342000

GET https://conductscience.org/api/papers/v1/35342000/cited_by?page=2